Microbiota as a modulator of drug response: targeting microbial–drug crosstalk in cancer therapy

癌症治疗 串扰 药品 生物 癌症研究 靶向治疗 癌症 疾病 医学 免疫学 药理学 药物发现 生物信息学 放射治疗 抗癌药物 药物治疗 靶向给药 药物开发 癌症治疗 精密医学
作者
Tianhao Zhao,Mingren Liu,L X Qiu,Hao Zhang,N. Zhang,Zaoqu Liu,Zhiwei Xia,Peng Luo,Jun Huang,Qi Cheng
出处
期刊:Gut microbes [Landes Bioscience]
卷期号:18 (1): 2651930-2651930 被引量:1
标识
DOI:10.1080/19490976.2026.2651930
摘要

In recent years, accumulating evidence has established mechanistic connections between the microbiota and the efficacy of anticancer treatments, encompassing microbial communities residing in the gut, within tumors, and across other tissue sites. Across diverse malignancies, distinct compositional and functional profiles of these microbial ecosystems have been associated with differential responses to chemotherapy, immunotherapy, and targeted agents, as observed in both clinical settings and experimental systems. It is now understood that microbial communities exert influence on drug activity through multiple pathways: they may compromise therapeutic efficacy by metabolic inactivation or structural modification of anticancer compounds, or, conversely, potentiate responses by enhancing tumor cell susceptibility. Furthermore, these communities modulate the tumor immune microenvironment, fostering antitumor immunity through augmented antigen presentation and effector cell function, or constraining immune responses via regulatory networks and immunosuppressive myeloid polarization. The crosstalk between microbial cues and signaling networks in malignant and surrounding stromal tissues is widely thought to influence therapeutic outcomes. Key challenges ahead involve proving causation, elucidating context-dependent mechanisms, and translating patient heterogeneity into robust biomarkers and targeted therapies. Anticancer interventions can reportedly alter microbial community structure and function, with therapy-associated dysbiosis potentially contributing to primary or acquired resistance. Microbiota-directed strategies, including transplantation, defined microbial consortia, targeted delivery systems, and lifestyle interventions, are under investigation, yet challenges remain in establishing causality, ensuring safety, and enabling patient stratification. Collectively, these insights establish a translational framework for rationally designed microbiota‒drug combination strategies aimed at enhancing anticancer therapeutic outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mingxing818完成签到,获得积分10
刚刚
刚刚
刚刚
初景发布了新的文献求助30
1秒前
1秒前
老八完成签到,获得积分10
1秒前
QINJINGRUI发布了新的文献求助10
1秒前
wuxiaojiao发布了新的文献求助10
1秒前
1秒前
wt完成签到 ,获得积分10
2秒前
2秒前
希望天下0贩的0的应助被发发采纳,获得10
2秒前
3秒前
4秒前
4秒前
4秒前
小二郎的应助被朗姆蓝莓采纳,获得10
5秒前
元谷雪发布了新的文献求助10
5秒前
showtime发布了新的文献求助30
5秒前
JunChou完成签到,获得积分10
5秒前
5秒前
Maestro_S的应助被Chenzr采纳,获得10
6秒前
6秒前
ding的应助被柴六斤采纳,获得10
7秒前
科研大佬修炼手册给科研大佬修炼手册的求助进行了留言
7秒前
科研狂人发布了新的文献求助10
7秒前
7秒前
sqqx发布了新的文献求助10
7秒前
大模型的应助被2499297293采纳,获得10
8秒前
8秒前
在望的应助被LW采纳,获得10
8秒前
8秒前
drizzle发布了新的文献求助10
8秒前
小6完成签到 ,获得积分10
8秒前
8秒前
jie完成签到,获得积分10
9秒前
9秒前
9秒前
情怀的应助被xu采纳,获得10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175556
求助须知:如何正确求助?哪些是违规求助? 9567240
关于积分的说明 21791502
捐赠科研通 7770174
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299